BI
Biogen Inc
🇩🇪XSTU.IDPGermanyHealthcare
€187.76EURup +1.76 (+0.95%)ClosedEnd of day10:41 PM
Price€187.76+1.76 (+0.95%)
Profile
- Healthcare
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US09062X1037
- CUSIP
- Not reported
Company
- Employees
- 7,500
- Headquarters
- Cambridge, United States
- Website
- https://www.biogen.com
- CEO
- Mr. Christopher A. Viehbacher
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $9.95B-0.49%down year on year
- Net income
- $835.09M-45.44%down year on year
- Gross margin
- 67.71%-6.65%down year on year
- Free cash flow
- $2.97B+59.89%up year on year
Other listings
- XNAS.BIIBNasdaq
- XETR.IDPXetra
- XFRA.IDPFrankfurt Stock Exchange
- XMEX.BIIBMexican Stock Exchange
- BVMF.BIIB34B3 - Brasil Bolsa Balcão
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.